Another month, another tumor board talk. The slides aren’t self-sufficient, I’m afraid, but the references might be a good starting point for learning more about TCHRLBCL1, or diffuse large B-cell lymphoma in general. I’d start with this excellent review article on DLBCL treatment, written by several NCI attendings2.
The final two slides, after the thank-you slide, are there just in case. I try to time the 30-minute talk to 20 minutes, counting on audience participation. If that fails and there is some time left over, I have a back-up.